Cholinergic mechanisms in the brain and their impairment in Alzheimer's disease
Tucek, S.
Ceskoslovenska Psychiatrie 83(1): 36-45
1987
ISSN/ISBN: 0069-2336 PMID: 3581254 Document Number: 304122
Document emailed within 1 workday
Related Documents
Mauri, M.; Sinforiani, E.; Bono, G.; Cittadella, R.; Quattrone, A.; Boller, F.ço.; Nappi, G. 2006: Interaction between Apolipoprotein epsilon 4 and traumatic brain injury in patients with Alzheimer's disease and Mild Cognitive Impairment Functional Neurology 21(4): 223-228Miyakawa, T. 1988: Brain pathology in Alzheimer's disease. Ultrastructure of amyloid fibrils in Alzheimer's disease and Down's syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 46(7): 1471-1474
Bufill, E.; Blesa, R. 2006: Alzheimer's disease and brain evolution: is Alzheimer's disease an example of antagonistic pleiotropy? Revista de Neurologia 42(1): 25-33
Lawrence, A.D.; Sahakian, B.J. 1995: Alzheimer disease, attention, and the cholinergic system Alzheimer Disease and Associated Disorders 9(Suppl 2): 43-49
Kurz, A.; Rüster, P.; Romero, B.; Zimmer, R. 1986: Cholinergic treatment strategies in Alzheimer's disease Der Nervenarzt 57(10): 558-569
Bradley, R.J.; Edge, M.T.; Freeman, A.M. 1991: The effects of cholinergic preparations in Alzheimer's disease Farmakologiia i Toksikologiia 54(3): 4-10
Clader, J.W. 1999: Recent advances in cholinergic drugs for Alzheimer's disease Current Opinion in Drug Discovery and Development 2(4): 311-320
Robert, P.H.; Gokalsing, E.; Bertogliati, C. 1999: Cholinergic hypothesis and Alzheimer's disease: the place of donepezil (Aricept) L'Encephale 25(Special Issue 5): 23-27; Discussion: 28-29
Pomara, N.; Stanley, M. 1986: The cholinergic hypothesis of memory dysfunction in Alzheimer's disease--revisited Psychopharmacology Bulletin 22(1): 110-118
Mukhin, V.N. 2013: Pathogenesis of the basal forebrain cholinergic dysfunction in Alzheimer's disease Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 99(7): 793-804
Oderfeld-Nowak, B. 1977: Effect of some brain lesions on cholinergic mechanisms of hippocampus (authors transl) Postepy Biochemii 23(4): 579-618
Niewiadomska, G.; Wyrzykowska, J.; Chechłacz, M. 2000: Does senile impairment of cholinergic system in rats concern only disturbances in cholinergic phenotype or the progressive degeneration of neuronal cell bodies? Acta Biochimica Polonica 47(2): 313-330
Braginskaia, F.I.; Zorina, O.M.; Pal'mina, N.P.; Gaintseva, V.D.; Burlakova, E.B.; Selezneva, N.D.; Kolykhalov, I.V.; Gavrilova, S.I. 2000: Certain biochemical blood markers in the process of cholinergic therapy in Alzheimer's disease Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 100(6): 29-32
Pepeu, G.; Vannucchi, M.G.; Spignoli, G. 1988: Cognitive deficits and cholinergic mechanisms in aging brain: investigations on potentially useful drugs Annali Dell'istituto Superiore di Sanita 24(3): 411-416
Murayam, S.; Saito, Y. 2007: Neuropathology of mild cognitive impairment Alzheimer's disease Rinsho Shinkeigaku 47(11): 912-914
Arai, H. 2007: Alzheimer's disease neuroimaging initiative and mild cognitive impairment Rinsho Shinkeigaku 47(11): 905-907
Gillen, T.E.; Gregg, K.M.; Yuan, H.; Kurth, M.C.; Krishnan, K.R. 2001: Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease Psychopharmacology Bulletin 35(2): 83-96
Smith, G. 2002: Is mild cognitive impairment bridging the gap between normal aging and Alzheimer's disease? Journal of Neural Transmission. Supplementum 2002(62): 97-104
Harbaugh, R.E. 1987: Intracerebroventricular cholinergic drug administration in Alzheimer's disease: preliminary results of a double-blind study Journal of Neural Transmission. Supplementum 24: 271-277
Williams, L.R.; Jodelis, K.S.; Donald, M.R. 1989: Regional stimulation of cholinergic function by nerve growth factor in an animal model of Alzheimer's disease Progress in Clinical and Biological Research 317: 1179-1192